What is Tramadol?
Tramadol is a centrally-acting synthetic opioid analgesic used for the treatment of moderate to moderately severe pain. It is unique among opioids because it has a dual mechanism of action: it binds to mu-opioid receptors and also inhibits the reuptake of serotonin and norepinephrine. This dual mechanism provides analgesic effects from both opioid and non-opioid pathways.
Tramadol is available as immediate-release (IR) tablets (50 mg), extended-release (ER) tablets (100, 200, 300 mg), and in combination products with acetaminophen. It is classified as a Schedule IV controlled substance in the United States due to its potential for abuse and dependence, though this risk is generally lower than that of traditional opioids like oxycodone or morphine.
Pharmacology & Mechanism
Tramadol exerts its analgesic effects through two complementary mechanisms:
- Mu-opioid receptor agonism: Tramadol itself has weak affinity for mu-opioid receptors, but its active metabolite O-desmethyltramadol (M1) has approximately 200 times greater affinity. The M1 metabolite is formed by CYP2D6 metabolism and is primarily responsible for the opioid analgesic effect.
- Monoamine reuptake inhibition: Tramadol inhibits the reuptake of serotonin (5-HT) and norepinephrine (NE) in the central nervous system, enhancing descending inhibitory pain pathways. This mechanism is similar to certain antidepressants (SNRIs) and contributes to analgesia independent of opioid receptor activity.
The pharmacokinetic profile of tramadol includes rapid oral absorption (bioavailability ~75%), peak plasma concentration at 2 hours (IR) or 12 hours (ER), hepatic metabolism primarily via CYP2D6 and CYP3A4, and renal excretion of metabolites with an elimination half-life of 6-7 hours.
Dosing Guidelines
Immediate Release (IR)
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Initial titration | 25 mg | Once daily (morning) | Days 1-3 |
| Titration step 1 | 25 mg | Increase by 25 mg/day every 3 days | Until 25 mg QID |
| Titration step 2 | 50-100 mg | Increase by 50 mg/day every 3 days | Until adequate relief |
| Maintenance | 50-100 mg | Every 4-6 hours as needed | Ongoing |
| Maximum | 400 mg/day | — | 300 mg/day if age ≥75 |
Extended Release (ER)
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Starting dose | 100 mg | Once daily | Swallow whole; do not crush/chew |
| Titration | Increase by 100 mg | Every 5 days | Based on tolerability and efficacy |
| Maximum | 300 mg/day | Once daily | Not recommended in renal impairment |
Special Populations
| Population | Recommendation | Max Daily Dose |
|---|---|---|
| Elderly (≥75 years) | Use IR formulation; start low, go slow | 300 mg/day (IR) |
| Renal impairment (CrCl <30) | IR: 50-100 mg Q12H; ER: NOT recommended | 200 mg/day (IR only) |
| Hepatic impairment (cirrhosis) | IR: 50 mg Q12H only | 100 mg/day |
| CYP2D6 poor metabolizers | May have reduced efficacy; consider alternative | Standard doses |
| CYP2D6 ultra-rapid metabolizers | Increased risk of toxicity; use lower doses | Reduce accordingly |
Dosing Pathway Diagram
Drug Interactions
| Interacting Drug | Mechanism | Clinical Effect | Action |
|---|---|---|---|
| SSRIs / SNRIs | Additive serotonin activity | Serotonin syndrome risk | Avoid or use with extreme caution |
| MAO inhibitors | Serotonin accumulation | Severe serotonin syndrome | Contraindicated (within 14 days) |
| CYP2D6 inhibitors (fluoxetine, paroxetine) | Reduced M1 metabolite formation | Decreased efficacy + serotonin risk | Consider alternative analgesic |
| CYP3A4 inhibitors (ketoconazole) | Increased tramadol levels | Enhanced opioid effects | Reduce dose |
| Carbamazepine | CYP3A4 induction | Reduced tramadol efficacy | May need dose increase or alternative |
| Benzodiazepines / CNS depressants | Additive CNS depression | Respiratory depression, sedation | Avoid combination; FDA black box warning |
| Warfarin | Possible PT/INR increase | Increased bleeding risk | Monitor INR closely |
Seizure Risk
Tramadol lowers the seizure threshold and can cause seizures, particularly at higher doses or in combination with other medications that lower the seizure threshold. The risk is increased in the following situations:
- Doses exceeding 400 mg/day
- History of epilepsy or seizure disorder
- Concurrent use of SSRIs, SNRIs, tricyclic antidepressants, or MAO inhibitors
- Concurrent use of other drugs that lower seizure threshold (antipsychotics, bupropion)
- Metabolic disorders (hypoglycemia, hyponatremia)
- Head trauma or CNS infections
- Alcohol or sedative withdrawal
Seizures typically occur at supratherapeutic doses and are most common within the first 24-48 hours of overdose. The risk of seizures at therapeutic doses is estimated at 0.5-1% but increases substantially with dose escalation.
Serotonin Syndrome
Because tramadol inhibits serotonin reuptake, it can cause serotonin syndrome, especially when combined with other serotonergic medications. Serotonin syndrome is a potentially life-threatening condition characterized by:
- Neuromuscular hyperactivity: tremor, clonus, myoclonus, hyperreflexia, rigidity
- Autonomic instability: tachycardia, hyperthermia, diaphoresis, diarrhea
- Altered mental status: agitation, confusion, delirium
Onset is typically within hours of adding a serotonergic drug or increasing the dose. Treatment involves discontinuing all serotonergic agents, supportive care, and in severe cases, cyproheptadine (a serotonin antagonist). The Hunter criteria are used for clinical diagnosis.
Worked Example
A 45-year-old patient weighing 70 kg with moderate pain, normal renal and hepatic function, prescribed immediate-release tramadol:
Titration: +25 mg every 3 days → 25 mg BID (Day 4-6) → 25 mg TID (Day 7-9) → 25 mg QID (Day 10-12)
Then: +50 mg every 3 days until 50-100 mg Q4-6H
Target maintenance: 50 mg Q6H = 200 mg/day
Maximum: 400 mg/day
Frequently Asked Questions
Is tramadol a narcotic?
Tramadol is classified as a Schedule IV controlled substance in the US (since 2014). While it is technically an opioid that acts on mu-opioid receptors, it was historically considered to have lower abuse potential than Schedule II opioids like oxycodone or hydrocodone. However, it can still cause dependence, tolerance, and withdrawal symptoms, and should be used with appropriate caution.
Can I take tramadol with acetaminophen or ibuprofen?
Tramadol can generally be taken with acetaminophen (Tylenol) or ibuprofen (Advil) for enhanced pain relief, as they work through different mechanisms. In fact, a combination product (Ultracet) contains tramadol 37.5 mg with acetaminophen 325 mg. However, if taking tramadol-acetaminophen combinations, be mindful of total daily acetaminophen intake (max 3-4 g/day) to avoid liver toxicity.
How long does tramadol take to work?
Immediate-release tramadol typically begins working within 30-60 minutes, with peak effects at 2-3 hours. Extended-release formulations have a slower onset but provide more consistent plasma levels over 24 hours with peak levels around 12 hours.
What are the withdrawal symptoms from tramadol?
Tramadol withdrawal can produce both typical opioid withdrawal symptoms (anxiety, insomnia, sweating, muscle aches, diarrhea) and atypical symptoms related to its serotonergic/noradrenergic effects (hallucinations, paranoia, panic attacks, confusion, tingling). Gradual dose tapering over 2-4 weeks is recommended to minimize withdrawal symptoms.